Notice of Results & Investor Presentation
Futura Medical plc announced that it will release its full year results for the year ended 31 December 2025 on Wednesday 29 April, with management hosting a webinar presentation on the same day at 10:00 BST via the Investor Meet Company platform. The company, known for its sexual health products like Eroxon®, is inviting existing and potential shareholders to attend the presentation, where questions can be submitted in advance or during the live event.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Futura Medical plc (AIM: FUM), the consumer healthcare Group behind Eroxon® and that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, will release its full year results for the year ended 31 December 2025 on Wednesday 29 April.
Management will be hosting a webinar relating to the results via the Investor Meet Company platform on Wednesday 29 at 10:00 BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9.00am BST the day before, or at any time during the live presentation.
Investors can register for the presentation via the following link: https://www.investormeetcompany.com/futura-medical-plc/register-investor. Investors who already follow Futura on the Investor Meet Company platform will automatically be invited.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.